Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R21CA289541 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food & Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multiple disease) versus ads with no reduced-risk claims, and examine effects on message and product perceptions, and interest in using the smokeless tobacco products. This study will also examine how smokers' reactions/interest may vary based on the product brand, and asses prior awareness/exposure to the authorized claims.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 (General Snus-Control Ads) | Other | Participants in this group will view 4 ads for the brand General Snus that do not include a modified risk claim. |
|
| Group 2 (General Snus-Multiple Disease Ads) | Experimental | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases. |
|
| Group 3 (General Snus- Lung Ads) | Experimental | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. |
|
| Group 4 (Copenhagen-Control Ads) | Experimental | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. |
|
| Group 5 (Copenhagen-Multiple Disease Ads) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Modified Risk Claim Type - None | Behavioral | Participants will view smokeless tobacco ads with no modified risk claim (control) |
|
| Measure | Description | Time Frame |
|---|---|---|
| General Relative Harm Perception | Single item measure asking participants how harmful they think daily use of the viewed smokeless tobacco product would be to their health compared to daily cigarette smoking, (1=a lot less harmful, 2=somewhat less harmful, 3=about the same, 4=somewhat more harmful, 5=a lot more harmful). Higher scores mean thinking the viewed smokeless tobacco product is more harmful than cigarettes. | Assessed in survey measures completed immediately after viewing the study stimuli |
| Perceptions of Perceived Relative Risks of Diseases | Assessment of perceived risks of getting various smoking related diseases from using the viewed smokeless tobacco product versus from smoking cigarettes. Responses to 6 parallel questions (each asking about a different disease) were averaged together in this composite item. The question stated: "If you used only [General Snus/Copenhagen - inserted based on brand condition] or only cigarettes every day, which product would make it more likely that you would get": 1) lung cancer; 2) heart disease; 3) mouth cancer; 4) stroke; 5) chronic bronchitis; 6) emphysema. Response options to each were on a 5 point scale from (1=much more likely with General Snus/Copenhagen to 5=much more likely with cigarettes). Results presented here are based on the averages responses to the six items. Higher scores mean thinking risks are greater from smoking cigarettes than from using the viewed smokeless tobacco product. | Assessed in survey measures completed immediately after viewing the study stimuli |
| Absolute Harm Perception | Single item measure asking participants how likely or unlikely they think the viewed smokeless tobacco product would be to cause serious health problems during their lifetime, if they used it every day (from 1=not at all likely to 5=extremely likely). Higher scores mean greater likelihood of thinking the product is harmful to health. | Assessed in survey measures completed immediately after viewing the study stimuli |
| Product Use Intentions |
| Measure | Description | Time Frame |
|---|---|---|
| Risk Message Recall | Participants are asked to recall (yes/no) if the ads they viewed include any statement saying that using the product can lower risks of certain diseases. | Assessed in survey measures completed immediately after viewing the study stimuli |
| Ad Persuasiveness |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Olivia A Wackowski, PhD, MPH | Rutgers University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rutgers Institute for Nicotine & Tobacco Studies | New Brunswick | New Jersey | 08901 | United States |
Not provided
| Label | URL |
|---|---|
| Information about FDA's authorization of modified risk order for Copenhagen snuff | View source |
| Information about FDA's authorization of modified risk order for General Snus products | View source |
Not provided
The study ad stimuli, survey instrument, codebook, and de-identified dataset will be deposited to a data repository - we anticipate this will be the National Addiction and HIV Data Archive Program (NAHDAP), currently managed by ICPSR at the University of Michigan.
The scientific community will be able to access the data at the end of the award period. All publications using the data will also reference the data location in NAHDAP/ICSPR using DOIs. ICPSR engages in long-term preservation of the research data upon receipt of a signed deposit form, including migration to new formats, platforms, and storage media as required. ICPSR has a commitment to designate a successor repository in the unlikely event that such a need arises.
To request access, interested researchers will use the standard processes at NAHDAP/ICSPR for requesting data.
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Group 1 (General Snus-Control Ads) | Participants in this group will view 4 ads for the brand General Snus that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 10, 2026 |
Not provided
Not provided
Not provided
Not provided
Not provided
Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. |
|
| Group 6 (Copenhagen- Lung Ads) | Experimental | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. |
|
| Product Brand - General Snus | Behavioral | Participants will views ads for the smokeless tobacco brand General Snus |
|
| Product Brand - Copenhagen | Behavioral | Participants will views ads for the smokeless tobacco brand Copenhagen |
|
| Modified Risk Claim Type - Multiple Diseases | Behavioral | Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
|
| Modified Risk Claim Type - Lung Cancer | Behavioral | Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
Assessment of intentions to use the viewed smokeless tobacco products based on averaging responses to three parallel questions: "Thinking about the ads you saw for [General Snus or Copenhagen] products, how interested, in the next 6 months, would you be in: 1) Using or trying these products? 2) Using these products as a way to quit or cut down on your cigarette smoking? 3) Completely switching from cigarettes to these products? Response options to each were on a 5 point scale from (1=not at all interested to 5=extremely interested). Results presented here are based on the averaged responses to these three items. Higher scores mean greater interest in using the products.
| Assessed in survey measures completed immediately after viewing the study stimuli |
A composite measure based on the average of 6 advertisement perceptions, asking participants to rate whether they agreed or disagreed that they ads they viewed: 1) included important information; 2) were understandable; 3) included believable information; 4) included credible information; 5) included information new to me; 6) make me want to learn more about those products. Response options were on a 6 point agreement scale from 1=strongly disagree to 6=strongly agree. Higher scores mean greater agreement that the ads were effective and persuasive. |
| Assessed in survey measures completed immediately after viewing the study stimuli |
| Claim Believability & Credibility | A composite measure based on the average of 2 claim perception items, asking participants to rate whether they agreed or disagreed that the modified-risk claim in the ads they viewed was : 1) believable 2) credible. Participants responded to this while seeing the claim again on the survey screen. Response options were on a 7 point agreement scale from 1=strongly disagree to 7=strongly agree. Higher scores mean greater agreement that the claims were believable and credible. | Assessed in survey measures completed immediately after viewing the study stimuli |
| Overall Perceived Claim Persuasiveness | A composite measure based on the average of 7 claim perception items, asking participants to rate whether they agreed or disagreed that the modified-risk claim in the ads they viewed was : 1) believable; 2) credible; 3) important; 4) new to me; 5) makes me think using this product could be less harmful to my health than smoking; 6) makes me more interested in trying this product; 7) would make me think seriously about completely switching to this product. Participants responded to this while seeing the claim again on the survey screen. Response options were on a 7 point agreement scale from 1=strongly disagree to 7=strongly agree. Higher scores mean greater agreement that participants thought the claim was persuasive/effective. | Assessed in survey measures completed immediately after viewing the study stimuli |
| Switching Comprehension | An item assessing participants' understanding of the need to completely switch to the smokeless tobacco product viewed in order to reduce risks. It said: Please answer the next question based on your understanding of the ads you viewed earlier. Based on the ads, [General Snus OR Copenhagen, inserted based on condition] can reduce a smoker's health risks if you: (Select all that apply)
| Assessed in survey measures completed immediately after viewing the study stimuli |
| FG001 |
| Group 2 (General Snus-Multiple Disease Ads) |
Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| FG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| FG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| FG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| FG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| COMPLETED |
|
| NOT COMPLETED |
|
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Group 1 (General Snus-Control Ads) | Participants in this group will view 4 ads for the brand General Snus that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus |
| BG001 | Group 2 (General Snus-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| BG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| BG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| BG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| BG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| BG006 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean | Full Range | years |
| |||||||||||||||
| Sex/Gender, Customized | Count of Participants | Participants |
| ||||||||||||||||
| Race/Ethnicity, Customized | Count of Participants | Participants |
| ||||||||||||||||
| Region of Enrollment | Number | participants |
| ||||||||||||||||
| Smoking frequency | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | General Relative Harm Perception | Single item measure asking participants how harmful they think daily use of the viewed smokeless tobacco product would be to their health compared to daily cigarette smoking, (1=a lot less harmful, 2=somewhat less harmful, 3=about the same, 4=somewhat more harmful, 5=a lot more harmful). Higher scores mean thinking the viewed smokeless tobacco product is more harmful than cigarettes. | Posted | Mean | Standard Deviation | score on a scale | Assessed in survey measures completed immediately after viewing the study stimuli |
|
|
| |||||||||||||||||||||||||||||||||||||||||
| Primary | Perceptions of Perceived Relative Risks of Diseases | Assessment of perceived risks of getting various smoking related diseases from using the viewed smokeless tobacco product versus from smoking cigarettes. Responses to 6 parallel questions (each asking about a different disease) were averaged together in this composite item. The question stated: "If you used only [General Snus/Copenhagen - inserted based on brand condition] or only cigarettes every day, which product would make it more likely that you would get": 1) lung cancer; 2) heart disease; 3) mouth cancer; 4) stroke; 5) chronic bronchitis; 6) emphysema. Response options to each were on a 5 point scale from (1=much more likely with General Snus/Copenhagen to 5=much more likely with cigarettes). Results presented here are based on the averages responses to the six items. Higher scores mean thinking risks are greater from smoking cigarettes than from using the viewed smokeless tobacco product. | Posted | Mean | Standard Deviation | score on a scale | Assessed in survey measures completed immediately after viewing the study stimuli |
| |||||||||||||||||||||||||||||||||||||||||||
| Primary | Absolute Harm Perception | Single item measure asking participants how likely or unlikely they think the viewed smokeless tobacco product would be to cause serious health problems during their lifetime, if they used it every day (from 1=not at all likely to 5=extremely likely). Higher scores mean greater likelihood of thinking the product is harmful to health. | Posted | Mean | Standard Deviation | score on a scale | Assessed in survey measures completed immediately after viewing the study stimuli |
| |||||||||||||||||||||||||||||||||||||||||||
| Primary | Product Use Intentions | Assessment of intentions to use the viewed smokeless tobacco products based on averaging responses to three parallel questions: "Thinking about the ads you saw for [General Snus or Copenhagen] products, how interested, in the next 6 months, would you be in: 1) Using or trying these products? 2) Using these products as a way to quit or cut down on your cigarette smoking? 3) Completely switching from cigarettes to these products? Response options to each were on a 5 point scale from (1=not at all interested to 5=extremely interested). Results presented here are based on the averaged responses to these three items. Higher scores mean greater interest in using the products. | Posted | Mean | Standard Deviation | score on a scale | Assessed in survey measures completed immediately after viewing the study stimuli |
| |||||||||||||||||||||||||||||||||||||||||||
| Secondary | Risk Message Recall | Participants are asked to recall (yes/no) if the ads they viewed include any statement saying that using the product can lower risks of certain diseases. | Posted | Count of Participants | Participants | Assessed in survey measures completed immediately after viewing the study stimuli |
| ||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Ad Persuasiveness | A composite measure based on the average of 6 advertisement perceptions, asking participants to rate whether they agreed or disagreed that they ads they viewed: 1) included important information; 2) were understandable; 3) included believable information; 4) included credible information; 5) included information new to me; 6) make me want to learn more about those products. Response options were on a 6 point agreement scale from 1=strongly disagree to 6=strongly agree. Higher scores mean greater agreement that the ads were effective and persuasive. | Posted | Mean | Standard Deviation | score on a scale | Assessed in survey measures completed immediately after viewing the study stimuli |
| |||||||||||||||||||||||||||||||||||||||||||
| Secondary | Claim Believability & Credibility | A composite measure based on the average of 2 claim perception items, asking participants to rate whether they agreed or disagreed that the modified-risk claim in the ads they viewed was : 1) believable 2) credible. Participants responded to this while seeing the claim again on the survey screen. Response options were on a 7 point agreement scale from 1=strongly disagree to 7=strongly agree. Higher scores mean greater agreement that the claims were believable and credible. | Participants in Groups 1 and 4 were not asked this question (to rate the modified risk claim they saw) because their ad conditions did not include a modified risk claim (i.e., no-claim control ads). | Posted | Mean | Standard Deviation | score on a scale | Assessed in survey measures completed immediately after viewing the study stimuli |
| ||||||||||||||||||||||||||||||||||||||||||
| Secondary | Overall Perceived Claim Persuasiveness | A composite measure based on the average of 7 claim perception items, asking participants to rate whether they agreed or disagreed that the modified-risk claim in the ads they viewed was : 1) believable; 2) credible; 3) important; 4) new to me; 5) makes me think using this product could be less harmful to my health than smoking; 6) makes me more interested in trying this product; 7) would make me think seriously about completely switching to this product. Participants responded to this while seeing the claim again on the survey screen. Response options were on a 7 point agreement scale from 1=strongly disagree to 7=strongly agree. Higher scores mean greater agreement that participants thought the claim was persuasive/effective. | Participants in Groups 1 and 4 were not asked this question (to rate the modified risk claim they saw) because their ad conditions did not include a modified risk claim (i.e., no-claim control ads). | Posted | Mean | Standard Deviation | score on a scale | Assessed in survey measures completed immediately after viewing the study stimuli |
| ||||||||||||||||||||||||||||||||||||||||||
| Secondary | Switching Comprehension | An item assessing participants' understanding of the need to completely switch to the smokeless tobacco product viewed in order to reduce risks. It said: Please answer the next question based on your understanding of the ads you viewed earlier. Based on the ads, [General Snus OR Copenhagen, inserted based on condition] can reduce a smoker's health risks if you: (Select all that apply)
| Posted | Count of Participants | Participants | Assessed in survey measures completed immediately after viewing the study stimuli |
|
One month
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Group 1 (General Snus-Control Ads) | Participants in this group will view 4 ads for the brand General Snus that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus | 0 | 213 | 0 | 213 | 0 | 213 |
| EG001 | Group 2 (General Snus-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases | 0 | 209 | 0 | 209 | 0 | 209 |
| EG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only | 0 | 203 | 0 | 203 | 0 | 203 |
| EG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen | 0 | 209 | 0 | 209 | 0 | 203 |
| EG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases | 0 | 209 | 0 | 209 | 0 | 209 |
| EG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only | 0 | 214 | 0 | 214 | 0 | 214 |
Not provided
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Olivia A. Wackowski | Rutgers Institute for Nicotine & Tobacco Studies | 732-848-9328 | olivia.wackowski@rutgers.edu |
| Feb 11, 2026 |
| Prot_SAP_001.pdf |
| ICF | No | No | Yes | Informed Consent Form | Apr 3, 2025 | May 16, 2025 | ICF_000.pdf |
| ID | Term |
|---|---|
| D064424 | Tobacco Use |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
| Female |
|
| Black, Non-Hispanic |
|
| Other, Non-Hispanic |
|
| Hispanic |
|
| 2+ Races, Non-Hispanic |
|
| Smoke some days |
|
Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases.
Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus
Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases
| OG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| OG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| OG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
|
Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| OG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| OG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
|
| OG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| OG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| OG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
|
| OG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| OG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
|
| OG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| OG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| OG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
|
| OG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| OG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| OG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
|
Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| OG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| OG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
|
| OG002 | Group 3 (General Snus- Lung Ads) | Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only. Product Brand - General Snus: Participants will views ads for the smokeless tobacco brand General Snus Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
| OG003 | Group 4 (Copenhagen-Control Ads) | Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim. Modified Risk Claim Type - None: Participants will view smokeless tobacco ads with no modified risk claim (control) Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen |
| OG004 | Group 5 (Copenhagen-Multiple Disease Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Multiple Diseases: Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| OG005 | Group 6 (Copenhagen- Lung Ads) | Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only. Product Brand - Copenhagen: Participants will views ads for the smokeless tobacco brand Copenhagen Modified Risk Claim Type - Lung Cancer: Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
|
|